These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38170469)

  • 1. RNA Oncological Therapeutics: Intracellular Hairpin RNA Assembly Enables MicroRNA-Triggered Anticancer Functionality.
    Morihiro K; Morita S; Harada N; Baba M; Yum J; Naito M; Miyata K; Nagae G; Okamoto A
    J Am Chem Soc; 2024 Jan; 146(2):1346-1355. PubMed ID: 38170469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Hairpin DNA Pair: Selective Cytotoxic Inducer through MicroRNA-Triggered DNA Self-Assembly.
    Morihiro K; Osumi H; Morita S; Hattori T; Baba M; Harada N; Ohashi R; Okamoto A
    J Am Chem Soc; 2023 Jan; 145(1):135-142. PubMed ID: 36538570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleic Acid-to-Small Molecule Converter through Amplified Hairpin DNA Circuits.
    Morihiro K; Tomida Y; Fukui D; Hasegawa M; Okamoto A
    Angew Chem Int Ed Engl; 2023 Oct; 62(44):e202306587. PubMed ID: 37704581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long double-stranded RNA-mediated RNA interference and immunostimulation: long interfering double-stranded RNA as a potent anticancer therapeutics.
    Chang CI; Lee TY; Dua P; Kim S; Li CJ; Lee DK
    Nucleic Acid Ther; 2011 Jun; 21(3):149-55. PubMed ID: 21749291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
    Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
    ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A One-Two-Three Multifunctional System for Enhanced Imaging and Detection of Intracellular MicroRNA and Chemogene Therapy.
    Liu X; Wang X; Ye S; Li R; Li H
    ACS Appl Mater Interfaces; 2021 Jun; 13(24):27825-27835. PubMed ID: 34124898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Onconase on double-stranded RNA in vitro.
    Saxena A; Saxena SK; Shogen K
    Anticancer Res; 2009 Apr; 29(4):1067-71. PubMed ID: 19414347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA therapeutics: the emerging anticancer strategies.
    Jain CK; Gupta A; Dogra N; Kumar VS; Wadhwa G; Sharma SK
    Recent Pat Anticancer Drug Discov; 2014; 9(3):286-96. PubMed ID: 24605908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J; Tian XF; Yang W
    World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
    Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as anti-cancer therapy.
    Garofalo M; Leva GD; Croce CM
    Curr Pharm Des; 2014; 20(33):5328-35. PubMed ID: 24479801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs modulate the chemosensitivity of tumor cells.
    Blower PE; Chung JH; Verducci JS; Lin S; Park JK; Dai Z; Liu CG; Schmittgen TD; Reinhold WC; Croce CM; Weinstein JN; Sadee W
    Mol Cancer Ther; 2008 Jan; 7(1):1-9. PubMed ID: 18187804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a small molecule against an oncogenic noncoding RNA.
    Velagapudi SP; Cameron MD; Haga CL; Rosenberg LH; Lafitte M; Duckett DR; Phinney DG; Disney MD
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5898-903. PubMed ID: 27170187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairpin dsRNA does not trigger RNA interference in Candida albicans cells.
    Staab JF; White TC; Marr KA
    Yeast; 2011 Jan; 28(1):1-8. PubMed ID: 20737430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
    Di Giorgio A; Tran TP; Duca M
    Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.
    Costales MG; Hoch DG; Abegg D; Childs-Disney JL; Velagapudi SP; Adibekian A; Disney MD
    J Am Chem Soc; 2019 Feb; 141(7):2960-2974. PubMed ID: 30726072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-sensitive and high efficiency detection of multiple non-small cell lung cancer-related miRNAs on a single test line in catalytic hairpin assembly-based SERS-LFA strip.
    Mao Y; Sun Y; Xue J; Lu W; Cao X
    Anal Chim Acta; 2021 Sep; 1178():338800. PubMed ID: 34482860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
    Ruiz AJ; Hadac EM; Nace RA; Russell SJ
    J Virol; 2016 Apr; 90(8):4078-4092. PubMed ID: 26865716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic microRNA and double-stranded RNA targeting the 3'-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells.
    Tsuda N; Kawano K; Efferson CL; Ioannides CG
    Int J Oncol; 2005 Nov; 27(5):1299-306. PubMed ID: 16211225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-stranded microRNA mimics can induce length- and passenger strand-dependent effects in a cell type-specific manner.
    Goldgraben MA; Russell R; Rueda OM; Caldas C; Git A
    RNA; 2016 Feb; 22(2):193-203. PubMed ID: 26670622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.